Author
Listed:
- Adèle Paul
(UMRESTTE, UMR T 9405, Université Lyon 1, Université Gustave Eiffel—IFSTTAR, Domaine Rockefeller, 8 Avenue Rockefeller, 69008 Lyon, France
Centre de Ressources en Pathologies Professionnelles et Environnementales, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 chemin du Grand Revoyet, 69495 Pierre Bénite, France)
- Johan Spinosi
(Santé Publique France, French National Public Health Agency, 12 rue du Val d'Osne, 94415 Saint-Maurice, France)
- Mounia El Yamani
(Santé Publique France, French National Public Health Agency, 12 rue du Val d'Osne, 94415 Saint-Maurice, France)
- Anne Maitre
(Occupational and Environmental Toxicology Laboratory, Biology and Pathology Institute, CHU Grenoble Alpes, 38700 La Tronche, France
EPSP Team, TIMC IMAG Laboratory, UMR CNRS 5525, Université Grenoble Alpes, 621 Avenue Centrale, 38400 Saint Martin d’Hères, France)
- Barbara Charbotel
(UMRESTTE, UMR T 9405, Université Lyon 1, Université Gustave Eiffel—IFSTTAR, Domaine Rockefeller, 8 Avenue Rockefeller, 69008 Lyon, France
Centre de Ressources en Pathologies Professionnelles et Environnementales, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165 chemin du Grand Revoyet, 69495 Pierre Bénite, France)
Abstract
Studying the human health impacts of pesticides and their endocrine disruptor (ED) effects is a public health concern. The aim of this study is to identify phytopharmaceutical active substances (PAS) that are an ED or are toxic on endocrine glands (TEG), and to propose an ED/TEG effect indicator. Five international official databases were analyzed to identify the occurrence of health outcomes for 458 PAS. Health outcomes targeting seven endocrine systems were selected. For each substance, the level of evidence of the collected information and the number of outcomes were used to affect a level of concern about ED/TEG effects. Among the substances studied, 10% had a global ED/TEG effect classified as ‘high concern’, 55% as ‘medium concern’, 9% as ‘low concern’, and 26% as ‘unknown’. Ten of the high ED/TEG concern substances and 170 medium or low concern substances were licensed in 2018 in France. The outcomes were mainly on the reproductive organs, thyroid, and adrenal glands. Eight of the 41 biocontrol products studied were classified: 5 were ‘high’ or ‘medium concern’ and 3 had ‘unknown effect’. Although the proposed ED/TEG indicator is not an official classification, it can be used as an epidemiological tool for classifying the occupational and environmental risks of substances in retrospective population studies and be useful for occupational health physicians.
Suggested Citation
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:7:p:3477-:d:525174. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.